 | Blueprint Medicines
www.fool.com - February 22 at 11:38 PM |
 | Blueprint Medicines to Present at Upcoming Investor Conferences
finance.yahoo.com - February 19 at 8:21 AM |
| Ipsen writes down $725M after largest-ever acquisition, trial woes
finance.yahoo.com - February 18 at 1:35 PM |
 | Blueprint Medicines (NASDAQ:BPMC) Price Target Cut to $103.00
www.americanbankingnews.com - February 18 at 10:06 AM |
| Svb Leerink Weighs in on Blueprint Medicines Corp's Q2 2020 Earnings (NASDAQ:BPMC)
www.americanbankingnews.com - February 17 at 2:40 AM |
| Blueprint Medicines (BPMC) Q4 Loss Narrows, Revenues Top Mark
finance.yahoo.com - February 14 at 2:58 PM |
| Edited Transcript of BPMC earnings conference call or presentation 13-Feb-20 1:30pm GMT
finance.yahoo.com - February 14 at 8:32 AM |
| Blueprint Medicines (NASDAQ:BPMC) Releases Quarterly Earnings Results, Beats Expectations By $0.36 EPS
www.americanbankingnews.com - February 13 at 9:08 PM |
| Blueprint Medicines (NASDAQ:BPMC) Earns "Buy" Rating from Cowen
www.americanbankingnews.com - February 13 at 4:35 PM |
 | Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates
www.nasdaq.com - February 13 at 1:42 PM |
| Blueprint Medicines Corporation (BPMC)
finance.yahoo.com - February 13 at 8:41 AM |
 | Blueprint Medicines EPS beats by $0.41, beats on revenue
seekingalpha.com - February 13 at 8:41 AM |
| Blueprint Medicines Q4 Earnings Preview
seekingalpha.com - February 12 at 11:45 PM |
| Stock To Watch: Blueprint Medicines (BPMC)
www.nasdaq.com - February 12 at 1:44 PM |
| Blueprint Medicines Corp (NASDAQ:BPMC) Expected to Announce Quarterly Sales of $24.02 Million
www.americanbankingnews.com - February 12 at 3:54 AM |
| Brokerages Anticipate Blueprint Medicines Corp (NASDAQ:BPMC) Will Post Earnings of -$1.71 Per Share
www.americanbankingnews.com - February 10 at 4:14 AM |
| Blueprint Medicines' NDA for Avapritinib Gets Extended Review
finance.yahoo.com - February 7 at 4:52 PM |
| Blueprint Medicine's Most Recent Raise Is A Necessary Desperation
seekingalpha.com - February 7 at 11:52 AM |
| Blueprint Medicines (BPMC) Set to Announce Earnings on Thursday
www.americanbankingnews.com - February 7 at 10:36 AM |
| FDA extends action date for Blueprint's avapritinib
seekingalpha.com - February 6 at 5:31 PM |
| Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor
finance.yahoo.com - February 6 at 12:30 PM |
| Blueprint Medicines Corp (NASDAQ:BPMC) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 1 at 5:31 AM |
| Blueprint Medicines Enters Oversold Territory (BPMC)
www.nasdaq.com - January 24 at 5:45 PM |
| Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
finance.yahoo.com - January 21 at 9:02 PM |
| Blueprint Secures Favorable FDA Approval For PDGFRA Exon 18 Mutant GIST
seekingalpha.com - January 17 at 7:21 AM |
| Here's Why We're Not Too Worried About Blueprint Medicines's (NASDAQ:BPMC) Cash Burn Situation
finance.yahoo.com - January 16 at 7:33 PM |
| Here's Why We're Not Too Worried About Blueprint Medicines's (NASDAQ:BPMC) Cash Burn Situation
finance.yahoo.com - January 16 at 9:32 AM |
| Blueprint Medicines lays out growth plans
seekingalpha.com - January 13 at 5:37 PM |
| Blueprint Medicines Announces 2020 Corporate Goals
finance.yahoo.com - January 13 at 5:37 PM |
 | Blueprint prices new cancer drug at $32,000 per month
www.marketwatch.com - January 10 at 3:35 PM |
| Blueprint Medicines' Ayvakit Gets FDA Nod for Rare Cancer
finance.yahoo.com - January 10 at 3:35 PM |
 | UPDATE 2-FDA approves Blueprint's stomach cancer therapy priced at $32,000 per month
www.cnbc.com - January 10 at 7:27 AM |
 | FDA approves Cambridge biotech's first-ever drug for cancer
www.bizjournals.com - January 9 at 8:59 PM |
| FDA approves Cambridge biotech's first-ever drug for cancer
finance.yahoo.com - January 9 at 8:59 PM |
| U.S. FDA approves Blueprint's therapy for rare type of stomach cancer
www.nasdaq.com - January 9 at 3:59 PM |
| FDA OKs Blueprint kinase inhibitor for GI tumor
seekingalpha.com - January 9 at 3:59 PM |
| Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
finance.yahoo.com - January 9 at 3:59 PM |
| Blueprint Medicines initiates U.S. application for pralsetinib
seekingalpha.com - January 8 at 5:05 PM |
| Blueprint Medicines Announces Top-line Data for Pralsetinib and Initiates Rolling NDA Submission to FDA for the Treatment of Patients with RET Fusion-Positive Non-Small Cell Lung Cancer
finance.yahoo.com - January 8 at 5:05 PM |
| CStone Pharmaceuticals and Blueprint Medicines Initiate Phase 1b/2 Clinical Trial of Fisogatinib in Combination with CS1001 for Patients with Hepatocellular Carcinoma
finance.yahoo.com - January 6 at 3:26 PM |
| Blueprint Medicines (BPMC) Up More Than 30% YTD: Here's Why
www.nasdaq.com - December 13 at 12:43 PM |
| Blueprint's (BPMC) Systemic Mastocytosis Study Data Impresses
www.nasdaq.com - December 10 at 5:18 PM |
| Biotech accelerator teams with investment firm for $210M fund raise
finance.yahoo.com - December 10 at 7:16 AM |
| Notable Thursday Option Activity: ETSY, BPMC, ALNY
www.nasdaq.com - December 5 at 5:18 PM |
| Why Is Blueprint Medicines (BPMC) Up 1.4% Since Last Earnings Report?
finance.yahoo.com - December 5 at 12:18 PM |
| Blueprint Medicines down 7% on bearish call at Deutsche Bank
seekingalpha.com - December 2 at 12:40 PM |
| Is Blueprint Medicines Corporation's (NASDAQ:BPMC) CEO Being Overpaid?
finance.yahoo.com - December 2 at 7:39 AM |
| Is Blueprint Medicines Corporation's (NASDAQ:BPMC) CEO Being Overpaid?
finance.yahoo.com - December 2 at 7:39 AM |
| Blueprint Medicines (BPMC) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - November 21 at 2:14 PM |
| Blueprint Medicines to Present at Jefferies 2019 London Healthcare Conference
finance.yahoo.com - November 14 at 2:19 PM |
